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Variability of total step activity 
in children with cerebral palsy: influence 
of definition of a day on participant retention 
within the study
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Abstract 
Background: Activity monitoring is important to establish accurate daily physical activity levels in children with 
cerebral palsy (CP). However, few studies address issues around inclusion or exclusion of step count data; in particular, 
how a valid day should be defined and what impact different lengths of monitoring have on retention of participant 
data within a study. This study assessed how different ‘valid day’ definitions influenced inclusion of participant data in 
final analyses and the subsequent variability of the data.
Results: Sixty-nine children with CP were fitted with a StepWatch™ Activity Monitor and instructed to wear it for 
a week. Data analysis used two broad definitions of a day, based on either number of steps in a 24 h monitoring 
period or the number of hours of recorded activity in a 24 h monitoring period. Eight children either did not use the 
monitor, or used it for only 1 day. The remaining 61 children provided 2 valid days of monitoring defined as >100 
recorded steps per 24 h period and 55 (90 %) completed 2 valid days of monitoring with ≥10 h recorded activity 
per 24 h period. Performance variability in daily step count was lower across 2 days of monitoring when a valid day 
was defined as ≥10 h recorded activity per 24 h period (ICC = 0.765) and, higher when the definition >100 recorded 
steps per 24 h period (ICC = 0.62). Only 46 participants (75 %) completed 5 days of monitoring with >100 recorded 
steps per 24 h period and only 23 (38 %) achieved 5 days of monitoring with ≥10 h recorded activity per 24 h period. 
Datasets of participants who functioned at GMFCS level II were differentially excluded when the criteria for inclusion 
in final analysis was 5 valid days of ≥10 h recorded activity per 24 h period, leaving datasets available for only 8 of 32 
participant datasets retained in the study.
Conclusion: We conclude that changes in definition of a valid day have significant impacts on both inclusion of 
participant data in final analysis and measured variability of total step count.
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Background
Cerebral palsy (CP) is the commonest cause of physical 
disability in childhood, with a prevalence of 2.11/1000 
live births [1]. Children with CP have impaired gross 
motor function which contributes to reduced activity 
levels compared to their typically developing peers [2–4]. 
The functional ability of children with CP can be classi-
fied by the Gross Motor Function Classification System 
(GMFCS), a valid and reliable 5 level system which clas-
sifies gross motor function of these children from I (least 
involved) to V (most severely involved) [5–7]. Ambula-
tory children with CP who function at GMFCS level I, II 
or III, have levels of walking activity which are between 
20 and 60  % that of their typically developing peers, 
with an average daily step count of 8440 step (range 
7478–9498) [2].
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Physical activity in childhood is increasingly being recog-
nised as important for children with CP to maintain opti-
mum health throughout their lifespan [3, 8–11]. Therefore, 
there is increased interest in using activity monitors in 
these children to understand how different interventions 
in the lower limb might impact on intensity and amount of 
walking activity in the community. Accelerometers are the 
device of choice in the neurologic population because they 
are more reliable for step detection than pedometers and 
can capture a wider range of information, including dura-
tion of activity, step rate and intensity of activity [12]. The 
StepWatch™ Activity Monitor is one such device and is a 
sealed waterproof, microprocessor controlled device that 
uses a combination of acceleration, position and timing 
to detect steps. To date, the StepWatch™ Activity Monitor 
has been used to quantitate daily activity levels in children 
with CP and adults with neurological disorders, to assess 
activity related change after an intervention, [13] and as an 
outcome measure in small clinical trials [14].
The reported accuracy of step detection by the Step 
Watch™ Activity Monitor is 99  % when compared to 
‘manual counting’ in both non-disabled adults [15] and 
children with CP [2]. This accuracy includes both indoor 
settings and controlled outdoor settings [15]. Further, 
the Step Watch™ Activity Monitor has been shown to be 
more accurate than other accelerometers in the detec-
tion of steps in the presence of a slow or shuffling gait or 
rollator use [16–18]. As such, the Step Watch™ Activity 
Monitor is regarded as one of the most accurate acceler-
ometers in the neurologic population and has been used 
as a criterion standard against which other monitors are 
compared [19]. However, the majority of studies test the 
variability in measurement of step activity in a researcher 
controlled environment and in comparison with a gold 
standard. Any variation in step detection can then be 
attributed to the device, not the participant.
In the free-living natural environment, variability in 
step activity from day to day is a consequence not only 
of measurement error in the device but also the variation 
that occurs as an interaction of the person’s choices and 
behaviour and the environment. In addition, participants 
may inadvertently confound data collection by removing 
a monitor during specific activities or putting the monitor 
on incorrectly for periods of time, potentially changing the 
sensitivity of step detection. All of these factors combined 
lead to what has been termed ‘performance variability’ in 
the free living environment [20]. Researchers can generally 
not influence how and when the monitor is worn in the 
community but can influence the final dataset depending 
on the way they analyse the raw step activity data, which 
requires decisions about whether to include or exclude 
24 h periods of monitoring when there appears to be very 
low step activity or reduced hours of activity [21].
Not all studies clearly report their decision making 
on the inclusion/exclusion of patient data from the final 
analysis and others adopt differing approaches to deal-
ing with datasets when the monitor has recorded lengthy 
time periods of non-activity. For example, early stud-
ies using the Step Watch defined valid data collection 
as when the monitor had recorded at least 8 h of clearly 
defined step activity over a 24  h period [22] or when 
there was less than 3  h of ‘inadequate’ monitoring dur-
ing the daytime hours of 6:00 a.m.–10:00 p.m. Inadequate 
monitoring was defined as wearing the monitor upside 
down, not wearing the monitor, or wearing the monitor 
incorrectly on the ankle (not in the correct plane) [2]. 
Other studies have defined a day of monitoring as 10  h 
of continuous recorded step activity during a 24 monitor-
ing period [23–26]; however, one study included data in 
the analysis if more than 100 steps was recorded on the 
monitor during the 24 h monitoring period [27].
In children with CP, Ishikawa et  al. have argued for 
extended periods of activity monitoring, with variation 
in length of monitoring based on GMFCS levels. The 
authors of that study defined an acceptable G coefficient 
as >0.8 (similar to an ICC of >0.8). Their reported mini-
mum number of days to achieve a G coefficient of  >0.8 
for total daily step count for children aged 6–14 was six 
for GMFCS I, five for GMFCS II and four for GMFCS 
III [28]. However, such prolonged periods of monitoring 
have the potential to adversely affect subject compliance 
in a study, particularly in the disabled population.
We are interested in developing a study to look at activ-
ity monitoring as a primary end-point after surgical 
intervention in children with CP. The primary goal of this 
study was therefore to determine how different defini-
tions of valid data collection over a 24 h period influenced 
the exclusion of participant data from study analysis and 
whether any bias would be introduced into the results by 
changing definitions of a valid day. A secondary goal was 
to determine the performance variability of measures of 
total step count over a 2 day period of monitoring in the 
free living environment, using the two common defini-
tions of a valid day present in the literature.
Methods
Participants
The data for this study were collected as part of two 
studies, both approved by the Northern X Regional 
Ethics Committee and the ADHB Research Office and 
conducted over a period of 3.5  years. Inclusion criteria 
were children with CP, GMFCS levels I to III and ages 
6–18 years, who were attending our service for clinically 
indicated 3-D gait analysis. Exclusion criteria were signif-
icant illnesses (such as major cardiac or respiratory disor-
ders), injury or surgery within the last 6 months that may 
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impact usual activity levels in the community or planned 
treatment following 3-DGA that precluded wearing of 
the monitor for a week.
The children were recruited when they attended a hos-
pital clinic for their 3-DGA assessment. Written consent 
was obtained from each child’s parent or guardian and 
assent from the child.
A Step Watch™ Activity Monitor (Orthocare Innova-
tions, Mountlake Terrace, WA, USA) was fitted to the less 
impaired lower limb using the strap according to manu-
facturer’s instructions. The monitor was then calibrated 
in clinic to each participant’s walking pattern. An accu-
racy check was performed by asking the child to walk 
at varying speeds in the clinic and manually correlating 
the triggered flashes from the internal LED light to the 
steps taken. Monitor calibration accuracy was established 
to manual counting and was achieved when greater than 
95 % for all participants. All participants were given ver-
bal and written instructions to wear the monitor for a 
continuous 7  day period, removing it only for sleeping, 
swimming, bathing and showering. Data from the moni-
tors were downloaded after being returned to the princi-
pal investigator by mail. Data collection occurred during 
the year, with exclusion of school holidays.
Data analysis
Previous work using the StepWatch™ Activity Monitor 
has found that both typically developing children and 
children with CP have lower and more varied activity 
levels on weekend days, possibly as the result of a less 
structured environment [22, 29]. We thus chose to ana-
lyse data only for the 5  week-days collected during the 
seven consecutive days of monitoring. The StepWatch™ 
Activity Monitor captures step activity of a single leg, so 
the step counts were doubled to obtain the overall step 
count.
In the first part of the data analysis, we applied increas-
ingly stringent definitions of a valid day to the patient 
datasets and determined the number of participant data-
sets consequently excluded from the final analysis. These 
criteria were based on either a required minimum num-
ber of recorded steps in a 24 h monitoring period (start-
ing at >100 steps and then 1000 steps, increased in 1000 
step increments) or a minimum number of hours of 
recorded activity in a 24 h monitoring period (increased 
in intervals of 30 min).
In the second part of the data analysis, we assessed the 
performance variability of measures of total step count 
in the free living natural environment. To assess how dif-
ferent definitions of a ‘valid day’ affected performance 
variability, we used two definitions commonly found in 
the literature to determine inclusion or exclusion of data 
from analysis:
1. When the monitor had recorded at least 100 steps 
over a 24 h period of monitoring
2. When the monitor had recorded at least 10  h of 
activity with less than 2 h of no recorded activity over 
a 24 h period of monitoring
Bland and Altman analyses were used to quantitate the 
performance variability between day one and day two 
[30]. Intra-class correlation coefficients (ICC) were also 
calculated with IBM SPSS Statistics Version 21 (SPSS 
Inc., Chicago, IL) utilising the two-way random, absolute 
agreement model to determine the variability of meas-
ures of total step count between day one and day two, 
using the two above definitions for a valid day.
Results
Table  1 presents the demographic data for all partici-
pants (n =  69) including gender, GMFCS level and sid-
edness of CP. The participant inclusions and exclusions 
that resulted from variations in (i) the definition of a 
‘valid day’ and (ii) the number of valid days of consecu-
tive monitoring required for final data analysis are shown 
in Fig. 1. Seven of the initially recruited 69 children had 
no recorded activity data and were excluded from the 
study. The reasons for the lack of recorded data were: no 
longer wanted to wear the monitor after enrolment in the 
study (n = 2), the monitor was lost (n = 4); and not want-
ing to repeat the assessment when no recorded activity 
was found on the returned monitor (presumed to have 
been worn upside down; n = 1). Of the remaining 62 par-
ticipants with Step Watch data, one participant had only 
1 day of recorded activity. For the remaining 61 partici-
pants, all had 2 or more days with >100 recorded steps in 
a 24 h period but only 55 participants had 2 or more valid 
days with ≥10 h in a 24 h period. 
Figure  2a, b show the percentage of participant data-
sets retained  in the study analysis as the requirements 
for data inclusion are changed. If ≥600 min of recorded 
activity per 24  h period (with no less than 2 consecu-
tive hours of no recorded activity) is defined as a valid 
day and the required number of valid days is only either 
2 or 3 × 24 h periods, then 55 (90 %) and 47 (77 %) of 
the participant datasets are eligible for inclusion in the 
final analysis (Fig. 2a). However, if the same criterion for 
dataset inclusion is applied and the required number 
of valid days is extended up to 5 ×  24  h periods, then 
only 23 (38 %) of the participant datasets meet the cri-
teria for inclusion in the final analysis. If the required 
length of recorded activity is extended up to ≥720 min 
of recorded activity per 24  h period (with no less than 
2 consecutive hours of no recorded activity), then the 
numbers of participants who achieved this wear time 
for 2 or 3  ×  24  h periods over the week decreases to 
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37 (61  %) and 24 (39  %) respectively. Conversely if the 
required wear time is reduced to 480 min (8 h) per 24 h 
period and the total wear period is either 2 or 3 × 24 h 
periods, then 59 (97 %) and 55 (90 %) participant data-
sets will meet criteria for inclusion.
If the criterion for dataset inclusion in the final analysis 
was the number of recorded steps per 24 h period, then 
only a small number of participant datasets are excluded 
when the number of steps required per 24  h period 
is >100 steps. The number of participants who achieved 
this wear time for 2 or 3 ×  24 h periods over the week 
are 61 (100 %) and 59 (97 %) respectively. Increasing the 
required wear period to 5  ×  24  h periods, reduces the 
number of participant datasets meeting the criteria for 
inclusion in the final analysis to 46 (75 %). If the required 
number of recorded steps is increased to  >1000 steps 
over a 24 h period, then the number of participants who 
achieved this wear time for 2 or 3 × 24 h periods over the 
week are not too dissimilar at 61 (100 %) and 57 (95 %) 
respectively. However, there was a progressive loss of 
participant datasets from the analysis  as the number of 
steps per 24 h period increase above 3000 steps (Fig. 2b).
The demographics of the retained participants, includ-
ing age, gender balance and sidedness of CP did not 
change significantly between 2  days and 5 valid days of 
monitoring for either ‘day’ definition, suggesting that 
changes in length of monitoring and ‘valid day’ defini-
tions did not differentially affect retention of subgroups 
participants within the final analysis. However, the more 
stringent criteria for definition of a day of  ≥10  h of 
2 days wear
>100 steps 
n-= 61
3 days wear
100 steps
N=59
4 days wear 
10 hours/day
n=34
Subjects lost n=17
M 8 F 9
GMFCS I 1 II 15 III 1
3 days wear 
10 hours/day
n=47
Subjects lost n=12
M 4 F 8
GMFCS I 4 II 7 III 1
2 days wear
>10 hours
n-= 55
Subjects lost n= 6
M  2  f 4
GMFCS I 2 II 3  III 1
4 days wear
100 steps
n=51
5 days wear 
>10 hours/day
n= 23
5 days wear
>100 steps
n=46
Lost to study
N=7
Only 2 days wear
Only 3 days wear
Only 4 days wear
All 5 days wear
Subjects lost n=23
M 15 F 8
GMFCS I 7 II 14 III 2
Fig. 1 Flow diagram for 69 study participants
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Fig. 2 Variation in the percentage of participant datasets eligible for 
inclusion in final analysis. a By minimum wear time per 24 h period 
and the required number of days of monitoring. b By number of 
recorded steps per 24 h monitoring period and the required number 
of days of monitoring
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recorded activity/24 h period led to a significant loss of 
children who functioned at GMFCS level II with a drop 
from 32 to 8 participants (75 % decrease), between 2 and 
5 valid days of monitoring. This was significantly differ-
ent from the retention of participants who functioned 
at GMFCS level II when the definition of a ‘valid day’ 
was >100 recorded steps over a 24 h period, with 28 of 35 
participants being retained in the study (20 % decrease) 
(p < 0.012, Fisher’s exact test).
Overall, there was less variability in measurements 
of total step count between day one and day two when 
a valid day was described as ≥10 h recorded activity per 
24 h period. Using this criterion for a valid day of moni-
toring, the ICC was 0.765 and the 95 % limits of agree-
ment between the measures for 2 valid days were −6154 
steps to 4797 steps, with a bias between day one and day 
two of −673 steps. Conversely, measurements of total 
step count between day one and day two were more vari-
able when a valid day was described as  >100 steps per 
24 h period. Then the ICC was 0.62 and the 95 % limits 
of agreement between total step count for day one and 
day two were wider at −9055 steps to 5782 steps, with a 
bias between day one and day two of 1636 steps. These 
data are shown graphically in Fig. 3a, b. Table 2 shows the 
results of the Spearman Brown prophecy and the number 
of days of activity monitoring predicted to achieve ICCs 
of 0.7, 0.8 and 0.9 respectively.
Discussion
The StepWatch™ Activity Monitor is widely used for 
assessing activity levels in a number of different popu-
lations, with total step count being the most frequently 
reported outcome. Monitoring is often for extended peri-
ods to capture different types of activity; however longer 
periods of monitoring also place increasing burden on 
the participants. In this study, using a convenience sam-
ple of children with CP, we found that many children do 
not achieve 5 full days of monitoring, regardless of how a 
valid day is defined. However, changes in the definition of 
a valid day made substantive differences to the number of 
participant datasets that were either retained or excluded 
from the final analysis. A low stringency criterion (>100 
recorded steps/24 h period) led to retention of more par-
ticipant datasets across all lengths of monitoring but had 
lower ICCs and more variability in step count between 
day one and day two. When a valid ‘day’ was defined 
as ≥10  h recorded step activity within a 24  h monitor-
ing period, 2 complete days of monitoring led to an ICC 
of 0.765 and less variability in total step count measures. 
However, extending the numbers of valid days required 
to five consecutive days of ≥10 h activity monitoring per 
24 h period, led to a 50 % drop in the numbers of partici-
pants with valid data-sets, with a disproportionate num-
ber of children functioning at GMFCS II level excluded 
from the analysis.
Our finding that many participants did not achieve 5 
valid days of monitor recorded activity is not restricted 
to children with disabilities. In a large field-based, lon-
gitudinal study, Mattocks et  al. required 7159 children 
aged 11 years wear an Actigraph monitor for seven days; 
however, 36  % wore the monitor for a valid 7  days and 
56 % wore it for between 3 and 6 valid days [31]. Whether 
incomplete accelerometer data is included in, or excluded 
from, the final analysis has some potential to increase 
bias, as it likely reflects differences in how sub-groups of 
participants comply with study requirements. For exam-
ple, Toftager et al. found that as the non-wear time of the 
monitor became shorter, more overweight and older ado-
lescents were excluded [32]. In our study, children with 
CP, GMFCS level II were significantly more likely to be 
excluded as the criteria for study inclusion became more 
stringent. Children with CP GMFCS level II walk with-
out walking aides, although have difficulty with stairs 
and activities on uneven ground. We are not certain why 
this group of children were differentially excluded but 
it is well known that children with CP can have associ-
ated behavioural and cognitive impairments as well as 
other medical conditions. These would potentially impact 
on study compliance [33]. This participant information 
was not available to this study but is worthy of further 
investigation.
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Fig. 3 Bland–Altman plots. a For 2 days data with >100 steps per 
24 h period. b For 2 days data >10 h per 24 h period
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We found in this study that monitoring for 2 consec-
utive days at ≥10  h per 24  h period, produced ICCs of 
0.765, with the Spearman Brown prophecy predicting 
that 2.5 days of monitoring would be required to achieve 
an ICC of 0.8. A lower stringency criterion for dataset 
inclusion led to lower ICCs of 0.62. This finding is con-
sistent with work by Rich et al. 2013 [34], who suggested 
that data from children with 2 days lasting >10 h of accel-
erometer monitoring is sufficient for monitoring in the 
typically developing population, achieving a reliability 
co-efficient of >0.8 calculated from the Spearman–Brown 
formula. In their study, shorter periods of monitoring 
per day (<10 h) necessitated more days of monitoring to 
achieve the same ICC. Addition of a weekend day did not 
alter the ICCs and was deemed not necessary.
Despite the ICC of 0.765 for the more stringent defi-
nition of a valid day, Bland–Altman analysis identified 
significant performance variability over 2 days with 95 % 
of repeated observations of total step counts expected 
to be within −6154 to 4797 steps of the first measure. 
The mean daily step count for those 55 participants was 
only 9870 steps, meaning that a very substantive change 
in daily total step count would be needed to prove effi-
cacy of an intervention in a randomised trial. In practical 
terms, positive changes of less than this amount would be 
blurred by the background variability. It is thus unlikely 
that total step count would be a useful measure in a small 
study due to its variability, influenced by both personal 
and environmental factors.
Bland–Altman analyses do not determine the cause 
of variation or determine which measure is more accu-
rate. The variability detected in total step count on a daily 
basis is likely a consequence of variation within partici-
pant activity levels over the school week coupled with 
missing data due to monitor misplacement or monitor 
removal and some degree of variation in sensitivity of 
step detection within the measurement device. A large 
study of 209 children with CP by Ishikawa et al. suggested 
that between a third and a half of the variance in total 
step count recorded by the StepWatch™ Activity Moni-
tor was related to the participant’s functional ability and 
another third to half due to unquantifiable factors [28]. 
Only a small percentage of the variation was attributable 
to the day of measurement. This raises the question as to 
whether an ICC of 0.8 should be the goal and whether 
it is better to include all days with recorded activity and 
accept the wide variation from day or day or include only 
those datasets with longer periods of activity monitor-
ing. The decision on this will likely vary, depending on 
the goal of the study but needs to be explicit in the study 
design. Certainly our data suggests that, as the stringency 
of the criterion for dataset inclusion increases, the more 
difficult it becomes to achieve complete datasets for all 
participants.
There were several limitations to this study. First there 
were only a small number of participants in the study, 
which may limit the generalizability of the results. Sec-
ond, activity levels could have been underreported for 
several reasons, e.g. the monitor could not be worn when 
swimming and therefore may underreport physical activ-
ity as swimming has been found to be a frequent leisure 
physical activity for adolescents with CP [3].  Further, 
school-aged children in our country often remove foot-
wear within the classroom so it is possible that the moni-
tor was removed at intervals during the day, leading to 
under-counting of physical activity.
Conclusions
In conclusion, how a ‘valid day’ is defined has significant 
impact on the size of the sample and which individual 
datasets are retained within the study analysis. Research-
ers need to balance the variability of the data collected 
by the StepWatch™ Activity Monitor against the burden 
to participants and the need to retain sufficient partici-
pants within a research study to achieve an adequate 
sample size. The variability in total step count from day 
to day is also significant in this group of children and 
makes it difficult to use the StepWatch™ Activity Moni-
tor as a primary outcome measure in a small interven-
tion trial. Researchers need to consider this variability 
to ensure the design of appropriately powered research 
studies.
Table 2 Performance variability of activity monitoring in the free living environment
ICC intra class correlation coefficient
Number of  
children
Variability of 2 days  
of monitoring (ICC)
Predicted number of days of monitoring 
required to achieve an ICC of
0.7 0.8 0.9
>100 steps per 24 h period 61 0.620 2.8 days 4.9 days 11 days
≥10 h per 24 h period 55 0.765 1.4 days 2.5 days 5.5 days
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